A Study to Evaluate the Relative Bioavailability of E7386 Following Oral Administration of Targeted Release (TR) Tablets Compared to an E7386 Immediate Release (IR) Tablet in Healthy Adult Participants
Clinical trial NCT04840927 · WITHDRAWN
Trial details
- NCT number
- NCT04840927
- Sponsor
- Eisai Limited
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-09
- Primary completion
- 2023-05-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.